Stay updated on Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden message with a Home button, replacing the study content with a minimal error layout and including site footer metadata.
    Difference
    20%
    Check dated 2026-09-20T20:45:38.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    A new site revision tag, v3.6.6, was added to the footer, and references to the previous revision (v3.6.5) along with several branding/links were removed.
    Difference
    0.3%
    Check dated 2026-08-30T22:01:29.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, indicating a minor platform update with no changes to study content or visible information.
    Difference
    0.1%
    Check dated 2026-08-09T09:20:54.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4, indicating a minor maintenance update to the page. This change does not modify study data, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-07-25T18:03:43.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.2 to v3.6.3, signaling a page refresh. This appears to be a metadata-level update rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-07-04T13:13:57.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    The page now displays an updated revision label from v3.6.0 to v3.6.2, indicating a newer build of the page without changes to visible content or features.
    Difference
    0.1%
    Check dated 2026-06-27T07:46:29.000Z thumbnail image

Stay in the know with updates to Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page.